Abcellera Biologics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $173k | 30k | 5.71 |
| 2023-09-30 | $170k | 37k | 4.60 |
| 2023-06-30 | $723k | 112k | 6.46 |
| 2022-12-31 | $854k | 84k | 10.13 |
| 2022-09-30 | $704k | 77k | 9.16 |
| 2022-06-30 | $778k | 73k | 10.64 |
| 2022-03-31 | $631k | 63k | 10.00 |
| 2021-12-31 | $1.3M | 92k | 14.50 |
| 2021-09-30 | $2.9M | 146k | 20.08 |
| 2021-06-30 | $1.1M | 51k | 22.01 |
| 2021-03-31 | $2.6M | 76k | 33.95 |
| 2020-12-31 | $8.0k | 200 | 40.00 |